FAILURE OF AN IMPLANTABLE CARDIOVERTER-DEFIBRILLATOR TO REDETECT VENTRICULAR-FIBRILLATION IN PATIENTS WITH A NONTHORACOTOMY LEAD SYSTEM

被引:56
|
作者
JUNG, W [1 ]
MANZ, M [1 ]
MOOSDORF, R [1 ]
LUDERITZ, B [1 ]
机构
[1] UNIV BONN,DEPT CARDIOVASC SURG,W-5300 BONN 1,GERMANY
关键词
IMPLANTABLE CARDIOVERTER-DEFIBRILLATOR; LEAD SYSTEMS; NONTHORACOTOMY; SUDDEN CARDIAC DEATH; ELECTROGRAM; ENDOCARDIAL;
D O I
10.1161/01.CIR.86.4.1217
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Background. Shock delivery of an implantable defibrillator may cause a change in the amplitude of endocardial electrograms and impair the detection of ventricular fibrillation. Thus, the effects of shock discharges on the amplitude of endocardial electrograms were evaluated in five patients undergoing implantation of a cardioverter-defibrillator in combination with a new nonthoracotomy lead system. Methods and Results. At implant, bipolar endocardial electrograms were recorded before each shock application, during ventricular fibrillation, during redetection of ventricular fibrillation in case the applied shock was ineffective, and at intervals of 5, 10, 20, 30, 60, and 120 seconds after each shock delivery. The amplitude of the endocardial electrograms decreased from 10.5+/-3.8 mV during sinus rhythm to 6.3+/-1.9 mV during initial ventricular fibrillation and declined to 2.2+/-1.3 mV during redetection of ventricular fibrillation. After successful termination, the following bipolar electrograms could be obtained at the predetermined intervals: 1.9+/-1.2 mV, 3.1+/-1.8 mV, 4.5+/-1.9 mV, 6.5+/-2.9 mV, 9.5+/-3.3 mV, and 10.4+/-3.8 mV. At predischarge testing, failure of redetection of ventricular fibrillation could be documented in two patients, requiring rescue external defibrillation in both cases to restore sinus rhythm. Conclusions. These findings demonstrate that the implantable cardioverter-defibrillator did not ensure reliable redetection of ventricular fibrillation in patients using the implanted nonthoracotomy lead system. Thus, the potential risk of sudden cardiac death may persist in these patients despite defibrillator therapy.
引用
收藏
页码:1217 / 1222
页数:6
相关论文
共 50 条
  • [41] Implantable cardioverter-defibrillator therapy in patients with nonischemic ventricular tachycardia or -fibrillation and normal left ventricular function
    Wichter, T
    Block, M
    MartinezRubio, A
    Brunn, J
    Weber, M
    Bansch, D
    Borggrefe, M
    CIRCULATION, 1996, 94 (08) : 763 - 763
  • [42] FAILURE OF DEFIBRILLATOR PADDLE AS MIMIC FOR SUBCUTANEOUS PATCH LEAD DURING NONTHORACOTOMY IMPLANTABLE CARDIOVERTER DEFIBRILLATOR LEAD CONFIGURATION ASSESSMENT
    PACHULSKI, RT
    KLEIMAN, RB
    JOSEPHSON, ME
    MARCHLINSKI, FE
    PACE-PACING AND CLINICAL ELECTROPHYSIOLOGY, 1992, 15 (09): : 1253 - 1257
  • [43] Approach to reduction of ventricular arrhythmias and implantable cardioverter-defibrillator therapies in patients with heart failure
    Sengupta, Jay
    Abdelhadi, Raed
    CURRENT OPINION IN CARDIOLOGY, 2013, 28 (03) : 337 - 343
  • [44] Age and the Risk of Ventricular Tachyarrhythmia in Patients With an Implantable Cardioverter-Defibrillator
    Aktas, Mehmet K.
    Younis, Arwa
    Saxena, Shireen
    Diamond, Alexander
    Ojo, Amole
    Kutyifa, Valentina
    Steiner, Hillel
    Steinberg, Jonathan S.
    Zareba, Wojciech
    Mcnitt, Scott
    Polonsky, Bronislava
    Rosero, Spencer Z.
    Huang, David T.
    Goldenberg, Ilan
    JACC-CLINICAL ELECTROPHYSIOLOGY, 2023, 9 (07) : 979 - 988
  • [45] Implantable cardioverter-defibrillator shocks in patients with ventricular assist devices
    Gkouziouta, A.
    Katsianis, A.
    Kostopoulou, A.
    Cokkinos, P. H.
    Karavolias, G.
    Maounis, T. H.
    Livanis, E.
    Theodorakis, G.
    Sfirakis, P.
    Adamopoulos, S.
    EUROPEAN HEART JOURNAL, 2013, 34 : 259 - 260
  • [46] Incidence and predictors of implantable cardioverter-defibrillator therapy and its complications in idiopathic ventricular fibrillation patients
    Blom, Lennart J.
    Visser, Marloes
    Christiaans, Imke
    Scholten, Marcoen F.
    Bootsma, Marianne
    van den Berg, Maarten P.
    Yap, Sing-Chien
    van der Heijden, Jeroen F.
    Doevendans, Pieter A.
    Loh, Peter
    Postema, Pieter G.
    Barge-Schaapsveld, Daniela Q.
    Hofman, Nynke
    Volders, Paul G. A.
    Wilde, Arthur A.
    Hassink, Rutger J.
    EUROPACE, 2019, 21 (10): : 1519 - 1526
  • [47] Spectral Analysis of Sustained and Non-Sustained Ventricular Fibrillation in Patients With an Implantable Cardioverter-Defibrillator
    Sanchez Munoz, Juan Jose
    Rojo Alvarez, Jose Luis
    Garcia Alberola, Arcadi
    Requena Carrion, Jesus
    Everss, Estrella
    Ortiz, Mercedes
    Martinez Sanchez, Juan
    Valdes Chavarri, Mariano
    REVISTA ESPANOLA DE CARDIOLOGIA, 2009, 62 (06): : 690 - 693
  • [48] Cognitive impairment after appropriate implantable cardioverter-defibrillator therapy for ventricular fibrillation
    Halas, Katarzyna
    Krzyzanowski, Krystian
    Krzyzanowska, Ewa
    Smurzynski, Pawel
    Ryczek, Robert
    Michalkiewicz, Dariusz
    Orski, Zbigniew
    Makowski, Karol
    Wierzbowski, Robert
    Gielerak, Grzegorz
    KARDIOLOGIA POLSKA, 2014, 72 (02) : 134 - 139
  • [49] Undersensing of ventricular fibrillation by a biventricular implantable cardioverter-defibrillator: What is the cause and the troubleshooting?
    Kien Vo Le
    Okamura, Hideo
    Nakajima, Kenzaburo
    Noda, Takashi
    Kusano, Kengo
    JOURNAL OF ARRHYTHMIA, 2019, 35 (02) : 276 - 278
  • [50] Selecting patients for an Implantable cardioverter-defibrillator
    Mittal, Suneet
    JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2008, 51 (03) : 297 - 299